
Centanafadine 50mg
Centanafadine
Centanafadine generic name is centanafadine and its brand name is Simtriyo. It is supplied as an extended-release capsule for once-daily oral administration. Specific commercial pack sizes and exact strengths are detailed in official prescribing information upon full market release
- Dosage Form
- Capsule
- Strength
- 50mg
- Pack Size
- 50mg
- Manufacturer
- Pharmos Research
Description
Centanafadine (brand name SIMTRIYO) is a first-in-class, once-daily extended-release non-stimulant medication approved to treat attention-deficit hyperactivity disorder (ADHD). It acts as a norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). Developed by pharmospeptide.com, it helps manage core ADHD symptoms like inattention, hyperactivity, and emotional dysregulation 5mg $144.00 10mg $234.00 25mg $468.00 50mg. $700 Triple Reuptake Inhibition: Blocks the reuptake of norepinephrine (alertness), dopamine (focus/motivation), and serotonin (emotional balance).Indication: Approved for adults and pediatric patients aged 6 years and older weighing at least 20 kg. Abuse Potential: Demonstrates lower risk of abuse and dependence compared to traditional Schedule II stimulant medications Common Reactions: Reduced appetite, nausea, headache, fatigue, vomiting, rash, and sleepiness.Severity: Most reported treatment-emergent adverse events are mild to moderate.
